Rein Therapeutics RNTX Balance Sheet (2016-2026)

NASDAQ RNTX
$0.82 +0.03 (+3.85%)
As of: Aug 21, 2026 · 11:17 AM EDT
Balance Sheet Jun2016 Sep2016 Dec2016 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation (Quarter)
0.20M0.21M0.23M0.24M0.26M0.27M0.27M0.28M0.29M0.36M
Assets
Current Assets
Cash & Equivalents (Quarter)
7.60M3.60M7.45M7.63M4.84M5.19M7.78M13.17M12.07M17.34M12.04M21.92M17.65M12.87M7.43M5.72M4.05M3.21M4.45M43.63M
Prepaid Assets (Quarter)
2.17M2.22M1.89M1.14M1.55M0.61M0.36M0.26M0.70M0.88M0.15M0.30M0.76M0.79M0.86M0.69M0.13M0.88M0.09M0.81M
Current Assets (Quarter)
54.42M48.18M39.99M33.55M27.05M21.87M17.11M13.95M12.79M18.27M12.76M23.16M18.68M13.66M8.33M6.60M5.17M4.33M5.45M41.45M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.14M0.13M0.11M0.10M0.08M0.07M0.05M0.04M0.03M0.02M0.01M0.00M0.00M0.00M0.00M0.00M
Goodwill (Quarter)
6.33M
Long-Term Investments (Quarter)
2.98M
Intangibles (Quarter)
13.50M
Goodwill & Intangibles (Quarter)
19.83M
Other Non-Current Assets (Quarter)
1.00M1.71M
Non-Current Assets (Quarter)
24.52M
Assets (Quarter)
65.97M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
4.47M
Notes Payables (Quarter)
4.92M
Payables (Quarter)
4.47M
Accumulated Expenses (Quarter)
1.54M
Other Accumulated Expenses (Quarter)
Current Leases (Quarter)
0.09M0.09M0.13M0.10M0.07M0.03M0.05M
Total Current Liabilities (Quarter)
9.71M
Non-Current Liabilities
Non-Current Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
45.01M
Minority Interest (Quarter)
Operating Leases (Quarter)
0.10M0.07M0.22M0.22M0.22M
Non-Current Deferred Tax Liability (Quarter)
1.06M
Other Non-Current Liabilities (Quarter)
0.12M0.28M
Total Non-Current Liabilities (Quarter)
8.26M7.52M7.75M9.47M7.52M7.24M
Total Liabilities (Quarter)
10.77M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)
55.20M
Liabilities and Shareholders Equity (Quarter)
65.97M
Retained Earnings (Quarter)
-413.48M
Treasury Shares (Quarter)
0.31M